Screener
Praxis Precision Medicines, Inc. PRAX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $474,761 | $357,329 |
| Marketable securities | 283,790 | 242,002 |
| Prepaid expenses and other current assets | 13,352 | 11,580 |
| Total current assets | 771,903 | 610,911 |
| Long-term marketable securities | 615,290 | 326,757 |
| Property and equipment, net | 492 | 147 |
| Operating lease right-of-use assets | 1,001 | 92 |
| Internal-use software | 773 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s total current assets?
- Praxis Precision Medicines, Inc. (PRAX) reported total current assets of $771.9M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s total current assets changed year-over-year?
- Praxis Precision Medicines, Inc.'s total current assets increased by 151.8% year-over-year, from $306.58M to $771.9M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total current assets has grown at a 15.1% compound annual growth rate (CAGR), from $302.33M to $610.91M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Praxis Precision Medicines, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude